Evidence map›Paper›PMID 35869098›Full record

ArticleScientific reports2022

Molecular docking analysis and evaluation of the antimicrobial properties of the constituents of Geranium wallichianum D. Don ex Sweet from Kashmir Himalaya.

Wajahat Rashid Mir, Basharat Ahmad Bhat, Muzafar Ahmad Rather, Showkeen Muzamil, Abdullah Almilaibary, Mustfa Alkhanani, Manzoor Ahmad Mir

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Antibacterial Activity ofJournal of microbiology and biotechnology · 2025
    Article
  9. Pioneering study of Egyptian Neem and Jojoba extracts with molecular docking combat hospital multidrug resistant bacteria.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  10. Article
  11. Assessment of the Anti-Foods (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Metabolic profiling and antimicrobial activity ofFrontiers in pharmacology · 2025
    Article
  14. 2,4-Di-tert-butylphenol from Endophytic FungiFrontiers in microbiology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Antibiotics (Basel, Switzerland) · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wajahat Rashid Mir *Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, J&K, 190006, India.
Basharat Ahmad Bhat *Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, J&K, 190006, India.
Muzafar Ahmad RatherMolecular Biology Laboratory, Faculty of Veterinary Sciences and Animal Husbandry, SKUAST-K, Srinagar, India.
Showkeen MuzamilMolecular Biology Laboratory, Faculty of Veterinary Sciences and Animal Husbandry, SKUAST-K, Srinagar, India.
Abdullah AlmilaibaryDepartment of Family and Community Medicine, Faculty of Medicine, Albaha University, Albaha, 65511, Kingdom of Saudi Arabia.
Mustfa AlkhananiBiology Department, College of Sciences, University of Hafr Al Batin, Hafar Al Batin, 31991, Kingdom of Saudi Arabia.
Manzoor Ahmad MirDepartment of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, J&K, 190006, India. drmanzoor@kashmiruniversity.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Geranium wallichianum D. Don ex Sweet is a well-known medicinal plant in Kashmir Himalya. The evidence for its modern medicinal applications remains majorly unexplored. The present study was undertaken to elucidate the detailed antimicrobial promises of different crude extracts (methanolic, ethanolic, petroleum ether, and ethyl acetate) of G. wallichainum against common human bacterial and fungal pathogens in order to scientifically validate its traditional use. The LC-MS analysis of G. wallichainum yielded 141 bioactive compounds with the vast majority of them having therapeutic applications. Determination of minimum inhibitory concentrations (MICs) by broth microdilution method of G. wallichainum was tested against bacterial and fungal pathogens with MICs ranging from 0.39 to 400 µg/mL. Furthermore, virtual ligands screening yielded elatine, kaempferol, and germacrene-A as medicinally most active constituents and the potential inhibitors of penicillin-binding protein (PBP), dihydropteroate synthase (DHPS), elongation factor-Tu (Eu-Tu), ABC transporter, 1,3 beta glycan, and beta-tubulin. The root mean square deviation (RMSD) graphs obtained through the molecular dynamic simulations (MDS) indicated the true bonding interactions which were further validated using root mean square fluctuation (RMSF) graphs which provided a better understanding of the amino acids present in the proteins responsible for the molecular motions and fluctuations. The effective binding of elatine, kaempferol, and germacrene-A with these proteins provides ground for further research to understand the underlying mechanism that ceases the growth of these microbes.

Indexed as

Anti-Infective AgentsGeraniumAnti-Bacterial AgentsBacteriaHumansKaempferolsMicrobial Sensitivity TestsMolecular Docking SimulationPlant ExtractsAnti-Bacterial AgentsAnti-Infective AgentsKaempferolsPlant Extracts

Identifiers

PMID35869098
PMCPMC9307801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.